Innovation for green industrialisation: an empirical assessment of innovation in Ethiopia’s cement, leather and textile sectors

Ethiopia has recently committed to economic transformation and industrialisation through a low-carbon development trajectory. Existing literature highlights innovation as a critical driver of industrialisation, and the need for ‘green’ innovations to improve resource productivity and reduce pollution. However, empirical studies investigating the nexus between green innovation systems and industrialisation in developing countries are limited. Based on nine semi-structured interviews and a survey of 117 firms, this paper assesses sectoral systems of innovation in Ethiopia’s cement, leather and textile sectors, with a view to understanding their functioning toward supporting green industrialisation. Results revealed low rates of product and process innovations among firms in Ethiopia. The main inhibitors of innovation are high costs of technology, inadequate finance and limited information. Improving competitiveness is the main driver of firms’ innovation, while reducing environmental impacts and meeting environmental regulations were among the least important motivators. Moreover, interactions among firms, government and other actors encourage innovation. The study therefore suggests enhancing coordination among key actors, providing financial incentives for firms, and enforcing environmental regulations

Health-industry linkages for local health: reframing policies for African health system strengthening

The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive prices, quality and reliability of supply. Meanwhile low-income African populations continue to suffer poor access to a broad range of medicines, despite major international funding efforts. A current wave of pharmaceutical industry investment in SSA is associated with active African government promotion of pharmaceuticals as a key sector in industrialization strategies. We present evidence from interviews in 2013–15 and 2017 in East Africa that health system actors perceive these investments in local production as an opportunity to improve access to medicines and supplies. We then identify key policies that can ensure that local health systems benefit from the investments. We argue for a ‘local health’ policy perspective, framed by concepts of proximity and positionality, which works with local priorities and distinct policy time scales and identifies scope for incentive alignment to generate mutually beneficial health–industry linkages and strengthening of both sectors. We argue that this local health perspective represents a distinctive shift in policy framing: it is not necessarily in conflict with ‘global health’ frameworks but poses a challenge to some of its underlying assumptions